Announce Date | 04/29/2025 |
EPS Normalized Actual | $1.72 (Beat by $0.11) |
EPS GAAP Actual | $1.72 (Beat by $0.11) |
Revenue Actual | $2.695B |
Revenue Surprise | Beat by $2695M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.18909 |
EPS GAAP Estimate | $2.18909 |
Revenue Estimate | $3.17041788B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 15.8 | 17.31 | 15.00702 | 16.29803 | 1 |
Dec 2028 | 14.34 | 19.07 | 13.65293 | 14.94213 | 3 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.25 | 1.25 | 2.695B | 4.53% | 2695M |
FQ4 2024 (Dec 2024) | 2.08 | 2.08 | 2.783B | 6.25% | 2783M |
FQ3 2024 (Sep 2024) | 1.38 | 1.38 | 2.867B | 6.77% | 2867M |
FQ2 2024 (Jun 2024) | 1.69 | 1.69 | 2.951B | 9.86% | 2951M |
FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 2.573B | 10.88% | 2573M |
FQ4 2023 (Dec 2023) | 0 | 0 | 2.609B | 6.32% | 2609M |
FQ3 2023 (Sep 2023) | 1.45 | 1.45 | 2.673B | 11.41% | 2673M |
FQ2 2023 (Jun 2023) | 1.56 | 1.56 | 2.66B | 15.79% | 2660M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.18909
Consensus Revenue Estimates
3.17041788B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 2.92538 | -- | 2.83354 | 2.99033 | 8 |
FQ2 2027 (Jun 2027) | 2.91843 | -- | 2.82681 | 2.98323 | 5 |
FQ1 2027 (Mar 2027) | 2.25823 | -- | 2.18734 | 2.30837 | 4 |
FQ4 2026 (Oct 2026) | 2.61951 | -- | 2.54899 | 2.70217 | 7 |
FQ3 2026 (Jul 2026) | 2.56745 | -- | 2.49833 | 2.64847 | 4 |
FQ2 2026 (Jun 2026) | 2.56892 | -- | 2.50204 | 2.67131 | 4 |
FQ1 2026 (Mar 2026) | 1.92714 | 35.14 | 1.87697 | 2.00395 | 4 |
FQ4 2025 (Oct 2025) | 2.23257 | 6.83 | 2.17246 | 2.30302 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 5.48B | -- | 5.35B | 5.57B | 3 |
FQ2 2027 (Jun 2027) | 5.15B | -- | 5.03B | 5.24B | 3 |
FQ1 2027 (Mar 2027) | 4.85B | -- | 4.73B | 4.93B | 3 |
FQ4 2026 (Oct 2026) | 3.61B | -- | 3.54B | 3.7B | 4 |
FQ3 2026 (Jul 2026) | 3.59B | -- | 3.52B | 3.68B | 5 |
FQ2 2026 (Jun 2026) | 2.6B | -- | 2.55B | 2.68B | 5 |
FQ1 2026 (Mar 2026) | 2.42B | -11.18 | 2.38B | 2.5B | 6 |
FQ4 2025 (Oct 2025) | 3.15B | 11.61 | 3.08B | 3.22B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.25 | 1.25 | 100% | |
FQ4 2024 (Dec 2024) | 2.08 | 2.08 | 100% | |
FQ3 2024 (Sep 2024) | 1.38 | 1.38 | 100% | |
FQ2 2024 (Jun 2024) | 1.69 | 1.69 | 100% | |
FQ1 2024 (Mar 2024) | 1.05 | 1.05 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 1.45 | 1.45 | 100% | |
FQ2 2023 (Jun 2023) | 1.56 | 1.56 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.7B | $2695M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.78B | $2783M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.87B | $2867M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.95B | $2951M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.57B | $2573M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.61B | $2609M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.67B | $2673M | 100% |
FQ2 2023 (Jun 2023) | $0B | $2.66B | $2660M | 100% |